ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07038
-0,13%
Bitcoin
66.211,95
-0,64%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Biostar Pharmaceuticals Inc (CE) (BSPM)

  7. Biostar Pharmaceuticals Inc (CE) (BSPM) News

BSPM

Biostar Pharmaceuticals (CE) (BSPM)

Biostar Pharmaceuticals Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:BSPM
DatumZeitQuelleÜberschriftSymbolFirma
08/01/201916h16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
24/08/201815h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/08/201814h51GlobeNewswire Inc.Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from NasdaqUSOTC:BSPMBiostar Pharmaceuticals Inc (CE)
25/07/201822h34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
06/07/201822h32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/07/201823h26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
30/05/201822h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
16/05/201822h12Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/04/201822h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/04/201822h02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/02/201822h53Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/02/201822h38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
01/02/201822h05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
28/12/201722h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
18/12/201722h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
04/12/201722h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/11/201722h11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/11/201723h02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/11/201722h34Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
28/08/201722h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/08/201715h01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
12/06/201723h16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/05/201722h24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/05/201723h01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/04/201722h17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
13/04/201722h05Edgar (US Regulatory)Annual Report (10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
03/04/201722h02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
24/02/201722h32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
09/02/201722h33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/01/201712h02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:BSPM

Kürzlich von Ihnen besucht

NASDAQ
GOOGL
Alphabet
AMEX
SPY
SPDR S&P 500
NASDAQ
AMZN
Amazon.com
FX
EURJPY
Euro vs Yen
NYSE
DIS
Walt Disney
AMEX
XLF
Financial Select Sector
CCOM
SILVER
SILVER
DBI
SDXP
SDAX
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLE
Energy Select Sector SPDR
CCOM
US100
US Tech 100
COIN
SOLUSD
Solana
USOTC
BASFY
BASF (QX)
USOTC
BNPQY
BNP Paribas (QX)
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten